- The ALAFIA AIVAS desktop supercomputer accelerates complex molecular dynamics and AI applications, delivering performance speedups as high as 80-100X for some research applications.
Researchers at the University of Miami have achieved a roughly 10x acceleration in complex HIV drug simulations, thanks to a new compute alliance with Miami-based ALAFIA. This dramatic speedup, powered by ALAFIA’s AIVAS Supercomputer, marks a potential breakthrough by enabling large-scale molecular dynamics modeling previously out of reach for the lab.
Molecular dynamics simulations are vital in the early stages of drug discovery, allowing scientists to predict how potential drug candidates might bind to and inhibit viral proteins essential for HIV replication. Yet these simulations are computationally intensive. Before this collaboration, the University of Miami lab faced limitations performing such timely, large-scale simulations. That reality hindered the pace of R&D and the ability to efficiently test multiple compounds or refine drug designs.
The ALAFIA AIVAS computer (shown above) helps tackle this challenge. Supporting more than 1,000 trillion operations per second, it provides the massive local processing power needed within the lab itself. This enables researchers to handle secure, encrypted workloads in real-time, sidestepping the latency and sometimes unpredictable costs associated with relying solely on cloud-based high-performance computing.
By overcoming previous computational bottlenecks, the AIVAS system allows UM researchers to explore more potential drug candidates, iterate on designs faster, and identify the most promising compounds for laboratory testing far more efficiently.
Filed Under: machine learning and AI
